<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0009">Whilst the viral hepatitis response would benefit from the support of international funding organisations, it is key that individual countries take responsibility for supporting the investment in elimination. China is a good example. Sustainable HBV programmes were established with support from private partnerships and leadership 
 <xref rid="JVEv5-bib-0004" ref-type="bibr">[4]</xref>. GAVI was one of the organisations that supported universal hepatitis B immunisation of infants in China. In addition, organisations such as GAVI, which recently announced prioritised investment in HBV birth-dose vaccines, can make a tremendous difference with raising awareness particularly through immunisation campaigns, especially in low- and middle-income countries. Georgia's HCV response is another example where a strong government leadership, combined with private investment from Gilead Sciences and technical support from the US Centers for Disease Control and Prevention and FIND/Unitaid led to successes.
</p>
